PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Nfkb2
|
ENSMUSG00000025225.16 | Nfkb2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Nfkb2 | mm39_v1_chr19_+_46293210_46293250 | 0.69 | 2.4e-11 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr13_+_43938251 | 18.07 |
ENSMUST00000015540.4
|
Cd83
|
CD83 antigen |
chr7_-_44181477 | 12.50 |
ENSMUST00000098483.9
ENSMUST00000035323.6 |
Spib
|
Spi-B transcription factor (Spi-1/PU.1 related) |
chr17_-_35424281 | 6.93 |
ENSMUST00000025266.6
|
Lta
|
lymphotoxin A |
chr19_+_46293210 | 6.56 |
ENSMUST00000236591.2
|
Nfkb2
|
nuclear factor of kappa light polypeptide gene enhancer in B cells 2, p49/p100 |
chr17_+_56259617 | 6.08 |
ENSMUST00000003274.8
|
Ebi3
|
Epstein-Barr virus induced gene 3 |
chr19_+_6391148 | 6.01 |
ENSMUST00000025897.13
ENSMUST00000130382.8 |
Map4k2
|
mitogen-activated protein kinase kinase kinase kinase 2 |
chr11_+_70548022 | 5.32 |
ENSMUST00000157027.8
ENSMUST00000072841.12 ENSMUST00000108548.8 ENSMUST00000126241.8 |
Eno3
|
enolase 3, beta muscle |
chr7_+_30121776 | 5.18 |
ENSMUST00000108175.8
|
Nfkbid
|
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, delta |
chrX_-_7537580 | 5.11 |
ENSMUST00000033486.6
|
Plp2
|
proteolipid protein 2 |
chr8_-_105357941 | 5.06 |
ENSMUST00000034351.8
|
Rrad
|
Ras-related associated with diabetes |
chr19_+_46293160 | 5.02 |
ENSMUST00000073116.13
|
Nfkb2
|
nuclear factor of kappa light polypeptide gene enhancer in B cells 2, p49/p100 |
chr7_-_19363280 | 4.90 |
ENSMUST00000094762.10
ENSMUST00000049912.15 ENSMUST00000098754.5 |
Relb
|
avian reticuloendotheliosis viral (v-rel) oncogene related B |
chr7_+_30121147 | 4.30 |
ENSMUST00000108176.9
|
Nfkbid
|
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, delta |
chr4_-_125021610 | 4.13 |
ENSMUST00000036188.8
|
Zc3h12a
|
zinc finger CCCH type containing 12A |
chr11_+_70548622 | 4.12 |
ENSMUST00000170716.8
|
Eno3
|
enolase 3, beta muscle |
chr11_-_54853729 | 3.95 |
ENSMUST00000108885.8
ENSMUST00000102730.9 ENSMUST00000018482.13 ENSMUST00000108886.8 ENSMUST00000102731.8 |
Tnip1
|
TNFAIP3 interacting protein 1 |
chr19_+_46292759 | 3.75 |
ENSMUST00000237330.2
|
Nfkb2
|
nuclear factor of kappa light polypeptide gene enhancer in B cells 2, p49/p100 |
chr17_+_35598583 | 3.62 |
ENSMUST00000081435.5
|
H2-Q4
|
histocompatibility 2, Q region locus 4 |
chr3_+_97565528 | 3.49 |
ENSMUST00000045743.13
|
Prkab2
|
protein kinase, AMP-activated, beta 2 non-catalytic subunit |
chr9_+_5308828 | 3.48 |
ENSMUST00000162846.8
ENSMUST00000027012.14 |
Casp4
|
caspase 4, apoptosis-related cysteine peptidase |
chr17_+_35643818 | 3.38 |
ENSMUST00000174699.8
|
H2-Q6
|
histocompatibility 2, Q region locus 6 |
chr11_+_70548513 | 3.16 |
ENSMUST00000134087.8
|
Eno3
|
enolase 3, beta muscle |
chr14_+_80237691 | 3.07 |
ENSMUST00000228749.2
ENSMUST00000088735.4 |
Olfm4
|
olfactomedin 4 |
chr8_-_105357872 | 3.05 |
ENSMUST00000212163.2
|
Rrad
|
Ras-related associated with diabetes |
chr7_+_67925718 | 3.03 |
ENSMUST00000210558.2
|
Fam169b
|
family with sequence similarity 169, member B |
chr14_-_30329765 | 2.91 |
ENSMUST00000112207.8
ENSMUST00000112206.8 ENSMUST00000112202.8 ENSMUST00000112203.2 |
Prkcd
|
protein kinase C, delta |
chr14_-_30348153 | 2.82 |
ENSMUST00000112211.9
ENSMUST00000112210.11 |
Prkcd
|
protein kinase C, delta |
chr11_-_23720953 | 2.82 |
ENSMUST00000102864.5
|
Rel
|
reticuloendotheliosis oncogene |
chr17_+_35643853 | 2.45 |
ENSMUST00000113879.4
|
H2-Q6
|
histocompatibility 2, Q region locus 6 |
chr6_+_68547717 | 2.43 |
ENSMUST00000196839.5
ENSMUST00000103327.3 |
Igkv12-98
|
immunoglobulin kappa variable 12-98 |
chr19_+_53517528 | 2.42 |
ENSMUST00000038287.7
|
Dusp5
|
dual specificity phosphatase 5 |
chr11_+_77576981 | 2.16 |
ENSMUST00000100802.11
ENSMUST00000181023.2 |
Nufip2
|
nuclear fragile X mental retardation protein interacting protein 2 |
chr11_+_69920542 | 1.99 |
ENSMUST00000232266.2
ENSMUST00000132597.5 |
Dlg4
|
discs large MAGUK scaffold protein 4 |
chrX_+_162692126 | 1.77 |
ENSMUST00000033734.14
ENSMUST00000112294.9 |
Ap1s2
|
adaptor-related protein complex 1, sigma 2 subunit |
chr5_+_90907207 | 1.60 |
ENSMUST00000031318.6
|
Cxcl5
|
chemokine (C-X-C motif) ligand 5 |
chr7_-_100951227 | 1.59 |
ENSMUST00000122116.8
ENSMUST00000120267.9 |
Atg16l2
|
autophagy related 16-like 2 (S. cerevisiae) |
chr7_+_16043502 | 1.57 |
ENSMUST00000002152.13
|
Bbc3
|
BCL2 binding component 3 |
chr2_-_3420056 | 1.56 |
ENSMUST00000115084.8
ENSMUST00000115083.8 |
Meig1
|
meiosis expressed gene 1 |
chr4_+_151012375 | 1.52 |
ENSMUST00000139826.8
ENSMUST00000116257.8 |
Tnfrsf9
|
tumor necrosis factor receptor superfamily, member 9 |
chr1_-_63153414 | 1.48 |
ENSMUST00000153992.2
ENSMUST00000165066.8 ENSMUST00000172416.8 ENSMUST00000137511.8 |
Ino80d
|
INO80 complex subunit D |
chr15_-_102154874 | 1.43 |
ENSMUST00000063339.14
|
Rarg
|
retinoic acid receptor, gamma |
chr1_-_63153675 | 1.42 |
ENSMUST00000097718.9
|
Ino80d
|
INO80 complex subunit D |
chr2_-_93292257 | 1.38 |
ENSMUST00000150508.8
|
Cd82
|
CD82 antigen |
chr2_-_3420102 | 1.30 |
ENSMUST00000115082.10
|
Meig1
|
meiosis expressed gene 1 |
chr17_-_88372315 | 1.28 |
ENSMUST00000235056.2
ENSMUST00000130379.9 |
Fbxo11
|
F-box protein 11 |
chr7_-_44702269 | 1.27 |
ENSMUST00000057293.8
|
Prr12
|
proline rich 12 |
chr3_-_116217579 | 1.26 |
ENSMUST00000106491.7
ENSMUST00000090464.7 |
Cdc14a
|
CDC14 cell division cycle 14A |
chr1_-_36982747 | 1.24 |
ENSMUST00000185964.3
|
Tmem131
|
transmembrane protein 131 |
chr8_+_79755194 | 1.24 |
ENSMUST00000119254.8
ENSMUST00000238669.2 |
Zfp827
|
zinc finger protein 827 |
chr2_-_37312881 | 1.21 |
ENSMUST00000112936.4
ENSMUST00000112934.8 |
Rc3h2
|
ring finger and CCCH-type zinc finger domains 2 |
chrX_+_162691978 | 1.21 |
ENSMUST00000069041.15
|
Ap1s2
|
adaptor-related protein complex 1, sigma 2 subunit |
chr9_-_106762818 | 1.17 |
ENSMUST00000185707.2
|
Rbm15b
|
RNA binding motif protein 15B |
chr6_-_69920632 | 1.09 |
ENSMUST00000198880.5
ENSMUST00000103371.3 |
Igkv12-38
|
immunoglobulin kappa chain variable 12-38 |
chr3_+_31149201 | 1.05 |
ENSMUST00000118470.8
ENSMUST00000029194.12 ENSMUST00000123532.2 |
Skil
|
SKI-like |
chr8_+_120729459 | 0.98 |
ENSMUST00000108972.4
|
Crispld2
|
cysteine-rich secretory protein LCCL domain containing 2 |
chr1_+_132996237 | 0.85 |
ENSMUST00000239467.2
|
Pik3c2b
|
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta |
chr19_-_46327024 | 0.84 |
ENSMUST00000236046.2
ENSMUST00000236980.2 ENSMUST00000235485.2 ENSMUST00000236061.2 ENSMUST00000236236.2 ENSMUST00000236768.2 ENSMUST00000236651.2 |
Cuedc2
|
CUE domain containing 2 |
chr19_-_46327071 | 0.81 |
ENSMUST00000235977.2
ENSMUST00000167861.8 ENSMUST00000051234.9 ENSMUST00000236066.2 |
Cuedc2
|
CUE domain containing 2 |
chr2_-_120144622 | 0.76 |
ENSMUST00000054651.8
|
Pla2g4f
|
phospholipase A2, group IVF |
chr17_-_36291087 | 0.75 |
ENSMUST00000055454.14
|
Prr3
|
proline-rich polypeptide 3 |
chr5_+_91051722 | 0.69 |
ENSMUST00000200681.4
ENSMUST00000075433.8 |
Cxcl2
|
chemokine (C-X-C motif) ligand 2 |
chr5_-_137529251 | 0.69 |
ENSMUST00000132525.8
|
Gnb2
|
guanine nucleotide binding protein (G protein), beta 2 |
chr8_+_124138163 | 0.68 |
ENSMUST00000071134.4
ENSMUST00000212743.2 |
Tubb3
|
tubulin, beta 3 class III |
chr3_+_31149247 | 0.65 |
ENSMUST00000117728.8
|
Skil
|
SKI-like |
chr10_+_127257077 | 0.63 |
ENSMUST00000168780.8
|
R3hdm2
|
R3H domain containing 2 |
chr1_+_74830675 | 0.62 |
ENSMUST00000006718.15
|
Wnt10a
|
wingless-type MMTV integration site family, member 10A |
chr17_+_36290743 | 0.60 |
ENSMUST00000087200.4
|
Gnl1
|
guanine nucleotide binding protein-like 1 |
chr7_-_125799570 | 0.60 |
ENSMUST00000009344.16
|
Xpo6
|
exportin 6 |
chr7_-_125799644 | 0.59 |
ENSMUST00000168189.8
|
Xpo6
|
exportin 6 |
chr10_+_80538482 | 0.56 |
ENSMUST00000095426.5
|
Izumo4
|
IZUMO family member 4 |
chr7_+_28988724 | 0.54 |
ENSMUST00000207714.2
ENSMUST00000048187.6 |
Ppp1r14a
|
protein phosphatase 1, regulatory inhibitor subunit 14A |
chr1_+_34840785 | 0.52 |
ENSMUST00000047664.16
ENSMUST00000211073.2 |
Arhgef4
SMIM39
|
Rho guanine nucleotide exchange factor (GEF) 4 novel protein |
chr13_-_111626562 | 0.49 |
ENSMUST00000091236.11
ENSMUST00000047627.14 |
Gpbp1
|
GC-rich promoter binding protein 1 |
chr8_+_79754980 | 0.47 |
ENSMUST00000087927.11
ENSMUST00000098614.9 |
Zfp827
|
zinc finger protein 827 |
chr4_+_124880223 | 0.46 |
ENSMUST00000030687.8
|
Rspo1
|
R-spondin 1 |
chr5_-_137529465 | 0.42 |
ENSMUST00000150063.9
|
Gnb2
|
guanine nucleotide binding protein (G protein), beta 2 |
chr11_-_84761637 | 0.39 |
ENSMUST00000168434.8
|
Ggnbp2
|
gametogenetin binding protein 2 |
chr2_-_164315634 | 0.33 |
ENSMUST00000017864.3
|
Trp53tg5
|
transformation related protein 53 target 5 |
chr4_+_140815644 | 0.29 |
ENSMUST00000051907.3
|
Spata21
|
spermatogenesis associated 21 |
chr7_+_18910340 | 0.28 |
ENSMUST00000117338.8
|
Eml2
|
echinoderm microtubule associated protein like 2 |
chr8_-_106015682 | 0.26 |
ENSMUST00000212922.2
ENSMUST00000212219.2 |
4931428F04Rik
|
RIKEN cDNA 4931428F04 gene |
chr8_-_106016097 | 0.23 |
ENSMUST00000171788.8
|
4931428F04Rik
|
RIKEN cDNA 4931428F04 gene |
chr11_-_84761538 | 0.21 |
ENSMUST00000170741.2
ENSMUST00000172405.8 ENSMUST00000100686.10 ENSMUST00000108081.9 |
Ggnbp2
|
gametogenetin binding protein 2 |
chr11_-_71928300 | 0.20 |
ENSMUST00000048207.10
|
Aipl1
|
aryl hydrocarbon receptor-interacting protein-like 1 |
chr11_-_84761472 | 0.18 |
ENSMUST00000018547.9
|
Ggnbp2
|
gametogenetin binding protein 2 |
chr6_-_83433357 | 0.15 |
ENSMUST00000186548.7
|
Tet3
|
tet methylcytosine dioxygenase 3 |
chr1_-_152778373 | 0.07 |
ENSMUST00000073441.13
ENSMUST00000111836.4 |
Smg7
|
Smg-7 homolog, nonsense mediated mRNA decay factor (C. elegans) |
chr1_+_149975782 | 0.05 |
ENSMUST00000035065.9
|
Ptgs2
|
prostaglandin-endoperoxide synthase 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 15.3 | GO:0002268 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
2.3 | 6.9 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
1.8 | 18.1 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
1.4 | 5.7 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
1.4 | 8.1 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.9 | 11.0 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.9 | 8.1 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.5 | 3.5 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.3 | 2.8 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.3 | 1.4 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
0.2 | 1.7 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.2 | 1.6 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.2 | 11.9 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.2 | 4.9 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.2 | 0.9 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.2 | 1.6 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.2 | 1.5 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
0.2 | 6.0 | GO:0006903 | vesicle targeting(GO:0006903) |
0.2 | 9.5 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.2 | 2.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 2.0 | GO:0098970 | receptor diffusion trapping(GO:0098953) postsynaptic neurotransmitter receptor diffusion trapping(GO:0098970) neurotransmitter receptor diffusion trapping(GO:0099628) |
0.1 | 0.8 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
0.1 | 1.3 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.1 | 1.2 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.1 | 1.7 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 12.6 | GO:0006096 | glycolytic process(GO:0006096) |
0.0 | 3.0 | GO:0060612 | adipose tissue development(GO:0060612) |
0.0 | 3.1 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.0 | 0.3 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.0 | 0.2 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.5 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.0 | 0.6 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.8 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.0 | 0.2 | GO:0044727 | DNA demethylation of male pronucleus(GO:0044727) |
0.0 | 6.1 | GO:0042098 | T cell proliferation(GO:0042098) |
0.0 | 0.1 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.0 | 3.5 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.0 | 1.0 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 1.2 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 2.9 | GO:0006310 | DNA recombination(GO:0006310) |
0.0 | 1.1 | GO:0006611 | protein export from nucleus(GO:0006611) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 15.3 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
1.0 | 7.7 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.9 | 12.6 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.9 | 3.5 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.7 | 9.5 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.6 | 4.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.2 | 3.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 2.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 3.1 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 2.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 1.6 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 5.7 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 19.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 3.0 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.9 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 11.1 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 1.1 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 1.7 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.2 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 1.5 | GO:0072686 | mitotic spindle(GO:0072686) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 5.7 | GO:0070976 | calcium-independent protein kinase C activity(GO:0004699) TIR domain binding(GO:0070976) |
0.9 | 12.6 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.6 | 9.5 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.4 | 6.0 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.3 | 3.5 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 2.0 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
0.3 | 4.1 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.2 | 15.3 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.2 | 9.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 5.1 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 3.5 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 2.4 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 6.6 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 1.3 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.1 | 0.8 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 4.0 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 1.4 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.9 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.9 | GO:0001727 | lipid kinase activity(GO:0001727) 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 6.1 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 1.5 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 17.2 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 4.0 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 10.5 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 1.3 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 1.7 | GO:0046332 | SMAD binding(GO:0046332) |
0.0 | 0.6 | GO:0005109 | frizzled binding(GO:0005109) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 15.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.2 | 6.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 5.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 6.0 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 8.1 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 2.8 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 4.6 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 4.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 2.0 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 3.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 2.4 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 1.5 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 1.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.7 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 1.3 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 1.6 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 1.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.9 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 1.4 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 15.3 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.3 | 12.6 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 3.5 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.2 | 3.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 5.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 3.5 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 1.3 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 1.6 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 1.7 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 0.7 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 2.3 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 1.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.0 | 0.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.9 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 1.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |